120 related articles for article (PubMed ID: 38160894)
1. Vitamin C enhances the sensitivity of osteosarcoma to arsenic trioxide via inhibiting aerobic glycolysis.
Liu Y; Yue J; Ren Z; He M; Wang A; Xie J; Li T; Liu G; He X; Ge S; Yuan Y; Yang L
Toxicol Appl Pharmacol; 2024 Jan; 482():116798. PubMed ID: 38160894
[TBL] [Abstract][Full Text] [Related]
2. Arsenic trioxide prevents osteosarcoma growth by inhibition of GLI transcription via DNA damage accumulation.
Nakamura S; Nagano S; Nagao H; Ishidou Y; Yokouchi M; Abematsu M; Yamamoto T; Komiya S; Setoguchi T
PLoS One; 2013; 8(7):e69466. PubMed ID: 23861973
[TBL] [Abstract][Full Text] [Related]
3. Combination of canstatin and arsenic trioxide suppresses the development of hepatocellular carcinoma.
Zhang F; Duan J; Song H; Yang L; Zhou M; Wang X
Drug Dev Res; 2021 May; 82(3):430-439. PubMed ID: 33244794
[TBL] [Abstract][Full Text] [Related]
4. Silencing SATB1 inhibits the malignant phenotype and increases sensitivity of human osteosarcoma U2OS cells to arsenic trioxide.
Zhang H; Su X; Guo L; Zhong L; Li W; Yue Z; Wang X; Mu Y; Li X; Li R; Wang Z
Int J Med Sci; 2014; 11(12):1262-9. PubMed ID: 25317073
[TBL] [Abstract][Full Text] [Related]
5. Bcl-2 hijacks the arsenic trioxide resistance in SH-SY5Y cells.
Wang J; Peng X; Yang D; Guo M; Xu X; Yin F; Wang Y; Huang J; Zhan L; Qi Z
J Cell Mol Med; 2022 Jan; 26(2):563-569. PubMed ID: 34910369
[TBL] [Abstract][Full Text] [Related]
6. Synergistic anti-tumor effects of arsenic trioxide and blue LED irradiation on human osteosarcoma.
Feng C; Gong R; Zheng Q; Yan G; He M; Lei H; Li X; Zhang L; Xu Z; Liu S; Yu M; Ma T; Gao M; Bamba D; Idiiatullina E; Zagidullin N; Pavlov V; Xu C; Yuan Y; Yang L
Int J Biol Sci; 2019; 15(2):386-394. PubMed ID: 30745828
[TBL] [Abstract][Full Text] [Related]
7. Heme oxygenase-1 silencing increases the sensitivity of human osteosarcoma MG63 cells to arsenic trioxide.
Zhong L; Wang Y; Li W; Gu J; Li X; Wang X; Yue Z; Mu Y; Bai J; Li R; Zhang H
Mol Cell Biochem; 2014 Jul; 392(1-2):135-44. PubMed ID: 24676542
[TBL] [Abstract][Full Text] [Related]
8. TG-interacting factor transcriptionally induced by AKT/FOXO3A is a negative regulator that antagonizes arsenic trioxide-induced cancer cell apoptosis.
Liu ZM; Tseng HY; Cheng YL; Yeh BW; Wu WJ; Huang HS
Toxicol Appl Pharmacol; 2015 May; 285(1):41-50. PubMed ID: 25791921
[TBL] [Abstract][Full Text] [Related]
9. Arsenic trioxide inhibits osteosarcoma cell invasiveness via MAPK signaling pathway.
Tingting R; Wei G; Changliang P; Xinchang L; Yi Y
Cancer Biol Ther; 2010 Aug; 10(3):251-7. PubMed ID: 20592496
[TBL] [Abstract][Full Text] [Related]
10. TP53 inhibitor PFTα increases the sensitivity of arsenic trioxide in TP53 wildtype tumor cells.
Wang H; Wang X; Xu L; Zhang J
FEBS Open Bio; 2022 Mar; 12(3):616-626. PubMed ID: 35030298
[TBL] [Abstract][Full Text] [Related]
11. Metformin ameliorates arsenic trioxide hepatotoxicity via inhibiting mitochondrial complex I.
Ling S; Shan Q; Liu P; Feng T; Zhang X; Xiang P; Chen K; Xie H; Song P; Zhou L; Liu J; Zheng S; Xu X
Cell Death Dis; 2017 Nov; 8(11):e3159. PubMed ID: 29095437
[TBL] [Abstract][Full Text] [Related]
12. Combination effects of arsenic trioxide and fibroblast growth factor receptor inhibitor in squamous cell lung carcinoma.
Lam SK; Leung LL; Li YY; Zheng CY; Ho JC
Lung Cancer; 2016 Nov; 101():111-119. PubMed ID: 27794399
[TBL] [Abstract][Full Text] [Related]
13. [Effects of vitamin C combined with arsenic trioxide on the apoptosis of Hep-2 cell].
Xu W; Shu C; Hu J; Ye Y
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2008 Feb; 22(4):171-3. PubMed ID: 18476623
[TBL] [Abstract][Full Text] [Related]
14. Metformin potentiates the effect of arsenic trioxide suppressing intrahepatic cholangiocarcinoma: roles of p38 MAPK, ERK3, and mTORC1.
Ling S; Xie H; Yang F; Shan Q; Dai H; Zhuo J; Wei X; Song P; Zhou L; Xu X; Zheng S
J Hematol Oncol; 2017 Feb; 10(1):59. PubMed ID: 28241849
[TBL] [Abstract][Full Text] [Related]
15. Arsenic trioxide induces apoptosis of p53 null osteosarcoma MG63 cells through the inhibition of catalase.
Wang Y; Wei Y; Zhang H; Shi Y; Li Y; Li R
Med Oncol; 2012 Jun; 29(2):1328-34. PubMed ID: 21308489
[TBL] [Abstract][Full Text] [Related]
16. Targeting metabolism with arsenic trioxide and dichloroacetate in breast cancer cells.
Sun RC; Board PG; Blackburn AC
Mol Cancer; 2011 Nov; 10():142. PubMed ID: 22093145
[TBL] [Abstract][Full Text] [Related]
17. [Experimental study of the anti-tumor effect of arsenic trioxide or thalidomide alone and combination of both for treatment of myelodysplastic syndrome model].
Lu J; Jin J; Xu WL
Zhonghua Er Ke Za Zhi; 2006 Mar; 44(3):228-33. PubMed ID: 16624066
[TBL] [Abstract][Full Text] [Related]
18. Cryptotanshinone enhances the effect of Arsenic trioxide in treating liver cancer cell by inducing apoptosis through downregulating phosphorylated- STAT3 in vitro and in vivo.
Shen L; Zhang G; Lou Z; Xu G; Zhang G
BMC Complement Altern Med; 2017 Feb; 17(1):106. PubMed ID: 28187727
[TBL] [Abstract][Full Text] [Related]
19. Using targeted magnetic arsenic trioxide nanoparticles for osteosarcoma treatment.
Li XS; Li WQ; Wang WB
Cancer Biother Radiopharm; 2007 Dec; 22(6):772-8. PubMed ID: 18158768
[TBL] [Abstract][Full Text] [Related]
20. Arsenic trioxide and ascorbic acid demonstrate promising activity against primary human CLL cells in vitro.
Biswas S; Zhao X; Mone AP; Mo X; Vargo M; Jarjoura D; Byrd JC; Muthusamy N
Leuk Res; 2010 Jul; 34(7):925-31. PubMed ID: 20171736
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
